Global /China /Healthcare /Drug Manufacturers - General /301331

Enwei Pharmaceutical Co., Ltd.

301331

• SHE: 301331 • Delayed

27.11CNY 0.5%

4.01 USD

As of 14 June 2026, Enwei Pharmaceutical Co., Ltd. has a market cap of $91.73M USD, ranking #26156 globally and #5936 in China. It ranks #2342 in the Healthcare sector, and #846 in the Drug Manufacturers - General industry.

Global Rank

26156

Country Rank

5936

Sector Rank

2342

Industry Rank

846

Key Stats

Market Cap

$91.73MUSD

621.53M CNY

Enterprise Value

$362.51MUSD

2.45B CNY

Revenue (TTM)

$129.81MUSD

879.6M CNY

EBITDA (TTM)

$15.81MUSD

106.98M CNY

Net Income (TTM)

$7.11MUSD

48.14M CNY

EBITDA Margin

12%

Profit Margin

5.5%

PE Ratio

58.5

PS Ratio

3.1

PB Ratio

2.5

EV/EBITDA

22.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yongjiang Xue open_in_new

Employees

1,548

Founded

2005

Website

enwei.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.5%	1%	3.4%	-5.6%	-16%	2%	7.2%	-2.2%	-20%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301331 恩威医药股份有限公司 Class A ISIN: CNE100005LC7 Shares Out.: Shares Outstanding: 27.327M¹ TV: TradingView: SZSE: 301331 SA: Stock Analysis: SHE: 301331 YF: Yahoo Finance: 301331.SZ GF: Google Finance: SHE: 301331 BA: Barron's: 301331 MS: Morningstar: XSHE: 301331	27.11 CNY	TV: TradingView: SZSE: 301331 SA: Stock Analysis: SHE: 301331 YF: Yahoo Finance: 301331.SZ GF: Google Finance: SHE: 301331 BA: Barron's: 301331 MS: Morningstar: XSHE: 301331

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Enwei Pharmaceutical Co., Ltd.

Enwei Pharmaceutical Co., Ltd. engages in the development and sale of Chinese medicines in China. The company offers drugs in the areas of gynecology, pediatrics, and respiratory system fields. The company was founded in 2005 and is based in Chengdu, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 59K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 54K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 31K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 20K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 18K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 17K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 830K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 597K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 393K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 350K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 315K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 299K%	20.5	Switzerland

chevron_leftBack